Hendrik Van Poppel
Katholieke Universiteit Leuven
CancerInternal medicineRadiologyUrologySurgeryPathologyOncologyProstateRenal cell carcinomaCarcinomaProstatectomyContext (language use)Prostate cancerNephrectomyBladder cancerLymph nodeProstate-specific antigenIn patientRadiation therapyMedicine
457Publications
83H-index
18.2kCitations
Publications 463
Newest
#1Ken Herrmann (University of Duisburg-Essen)H-Index: 70
#2Bernd Joachim Kraus (University of Rostock)
Last. Wim J.G. Oyen (Humanitas University)H-Index: 111
view all 8 authors...
Source
Abstract null null Background null The burden of urological diseases is rising as the worldwide population ages. Although specialist urological provision is needed, a large proportion of these conditions will be managed in primary care. The importance of including urology in medical education currently remains unclear. null null null Objective null To provide recommendations on undergraduate medical education for urology in Europe. null null null Design, setting, and participants null A three-ro...
Source
#1Gaëtan Devos (Katholieke Universiteit Leuven)H-Index: 6
#2Wout Devlies (Katholieke Universiteit Leuven)H-Index: 3
Last. Wouter Everaerts (Katholieke Universiteit Leuven)H-Index: 23
view all 12 authors...
Patients with high-risk prostate cancer treated with curative intent are at an increased risk of biochemical recurrence, metastatic progression and cancer-related death compared with patients treated for low-risk or intermediate-risk disease. Thus, these patients often need multimodal therapy to achieve complete disease control. Over the past two decades, multiple studies on the use of neoadjuvant treatment have been performed using conventional androgen deprivation therapy, which comprises lute...
Source
#1Eduard RousselH-Index: 4
#2Lisa KingetH-Index: 1
Last. Maarten AlbersenH-Index: 27
view all 11 authors...
Source
#1Elio MazzoneH-Index: 15
#2Giorgio GandagliaH-Index: 55
Last. R. Jeffrey KarnesH-Index: 72
view all 25 authors...
Source
#1Eduard Roussel (Katholieke Universiteit Leuven)H-Index: 4
#2Lisa Kinget (Katholieke Universiteit Leuven)H-Index: 1
Last. Hendrik Van Poppel (Katholieke Universiteit Leuven)H-Index: 83
view all 13 authors...
BACKGROUND Glandular metastases (GM) have been associated with improved survival in metastatic clear cell renal cell carcinoma (m-ccRCC). We aimed to molecularly characterize m-ccRCC with GM. MATERIAL AND METHODS We performed a retrospective cohort study on all m-ccRCC patients with available tissue at our institution, diagnosed with metastatic disease from 2000 to 2019. We determined previously described angiogenesis- and immune-related gene expression signatures (GES) and ccrcc molecular subty...
Source
#1Hendrik Van Poppel (Katholieke Universiteit Leuven)H-Index: 83
#2Monique J. Roobol (EUR: Erasmus University Rotterdam)H-Index: 74
Last. Manfred P. Wirth (TUD: Dresden University of Technology)H-Index: 67
view all 8 authors...
Abstract null null Background null Recommendations against prostate-specific antigen (PSA) testing in 2012 have increased advanced-stage diagnosis and prostate cancer–specific mortality rates. null null null Objective null To present the position of the European Association of Urology (EAU) in 2021 and provide recommendations for the use of PSA testing as part of a risk-adapted strategy for the early detection of prostate cancer. null null null Evidence acquisition null The authors combined thei...
Source
#1Hendrik Van Poppel (Katholieke Universiteit Leuven)H-Index: 83
#2Renée Hogenhout (Erasmus University Medical Center)H-Index: 2
Last. Monique J. Roobol (Erasmus University Medical Center)H-Index: 74
view all 6 authors...
Abstract null null Context null Overdiagnosis as the argument to stop prostate cancer (PCa) screening is less valid since the introduction of new technologies such as risk calculators (RCs) and magnetic resonance imaging (MRI). These new technologies result in fewer unnecessary biopsy procedures and fewer cases of both overdiagnosis and underdetection. Therefore, we can now adequately respond to the growing and urgent need for a structured risk assessment to detect PCa early. null null null Obje...
Source
#1Eduard Roussel (Katholieke Universiteit Leuven)H-Index: 4
#2Annelies Verbiest (Katholieke Universiteit Leuven)H-Index: 7
Last. Liesbeth De Wever (Katholieke Universiteit Leuven)H-Index: 9
view all 16 authors...
Abstract null null Background null Trials with adjuvant vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) failed to demonstrate meaningful benefit in clinically high-risk, fully resected clear cell renal cell carcinoma (ccRCC). We evaluated whether the ccrcc1-4 molecular subtypes and gene expression signatures (GES) are associated with outcomes in this setting. null null null Materials and Methods null We determined molecular subtypes as well as angiogenesis- an...
Source
#1Carlo Andrea Bravi (UniSR: Vita-Salute San Raffaele University)H-Index: 10
#2M. DroghettiH-Index: 3
Last. Riccardo SchiavinaH-Index: 40
view all 34 authors...
Abstract null null Background null The optimal definition and prognostic significance of persistently elevated prostate-specific antigen (PSA) after salvage lymph node dissection (sLND) for node-only recurrent prostate cancer (PCa) remain unknown. null null null Objective null To assess the definition and clinical implications of persistently elevated PSA after sLND for node-only recurrent PCa after radical prostatectomy. null null null Design, setting, and participants null The study included 5...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.